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SID lysine requirement of immunologically and physically castrated male pigs 
during the grower, early and late finisher periods 
Abstract 
The main objective of this experiment was to determine the standardized ileal digestible (SID) Lys 
requirement of immunologically castrated (IC) and physically castrated (PC) male pigs during 3 growth 
phases. An additional objective was to compare the ADFI of PC and IC after the second anti-gonadotropin 
releasing factor (GnRF) injection. Three hundred male pigs (PIC 359 × C29), 150 each of IC and PC, were 
allotted to 1 of 5 treatments: 80, 90, 100, 110, or 120% of the estimated Lys requirement using the NRC 
(2012) modeling program. Pigs remained on the same treatment throughout each of the 3 phases. Lysine 
requirements were determined at 3 stages of growth starting at a BW of 30.0 ± 0.8, 64.7 ± 1.4, and 111.9 
± 1.9 kg for IC and 32.4 ± 0.6, 69.8 ± 1.0, and 114.5 ± 1.3 kg for PC. Anti-GnRF injections were 
administered to IC at 11.5 and 19 wk (average BW = 96.3 ± 1.8 kg) of age. The one-slope broken line 
regression and quadratic plateau models were used, and the best model was selected based on the 
Akaike information criterion. The IC SID Lys requirements based on ADG were 1.03, 0.97, and 0.55% and 
for G:F, the requirements were 0.99, 0.72, and 0.55% for phases 1, 2, and 3, respectively. For PC, the SID 
Lys requirements based on ADG were 0.86, 0.62, and 0.47% and for G:F were 0.86, 0.58, and 0.47% for 
phases 1, 2, and 3, respectively. Immunologically castrated pigs had greater SID Lys requirements for 
phases 1 and 2 compared to PC (0.17 and 0.35 percentage points greater for ADG and 0.13 and 0.14 
percentage points greater for G:F for phases 1 and 2, respectively). After the second injection, when IC 
pigs are believed to become physiologically more similar to PC pigs, the SID Lys requirements continue to 
be greater for IC (0.55 vs. 0.47% for both ADG and G:F). The ADFI of IC increased 4 d after the second 
injection relative to PC. By 2 wk post second injection, the ADFI of IC exceeded that of PC (P < 0.05). 
Adopting immunological castration as a management tool requires an understanding that IC need to be 
fed differently compared to PC, to maximize growth performance. Immunologically castrated pigs have a 
greater SID Lys requirement throughout the grower and finishing periods compared to the PC. 
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The main objective of this experiment was to determine the standardized ileal digestible (SID) 
Lys requirement of immunologically castrated (IC) and physically castrated (PC) male pigs 
during 3 growth phases. An additional objective was to compare the ADFI of PC and IC after the 
second anti-gonadotropin releasing factor (GnRF) injection. Three hundred male pigs (PIC 359 
× C29), 150 each of IC and PC, were allotted to 1 of 5 treatments: 80, 90, 100, 110, or 120% of 
the estimated Lys requirement using the NRC (2012) modeling program. Pigs remained on the 
same treatment throughout each of the 3 phases. Lysine requirements were determined at 3 
stages of growth starting at a BW of 30.0 ± 0.8, 64.7 ± 1.4, and 111.9 ± 1.9 kg for IC and 32.4 ± 
0.6, 69.8 ± 1.0, and 114.5 ± 1.3 kg for PC. Anti-GnRF injections were administered to IC at 11.5 
and 19 wk (average BW = 96.3 ± 1.8 kg) of age. The one-slope broken line regression and 
quadratic plateau models were used, and the best model was selected based on the Akaike 
information criterion. The IC SID Lys requirements based on ADG were 1.03, 0.97, and 0.55% 
and for G:F, the requirements were 0.99, 0.72, and 0.55% for phases 1, 2, and 3, respectively. 
For PC, the SID Lys requirements based on ADG were 0.86, 0.62, and 0.47% and for G:F were 
0.86, 0.58, and 0.47% for phases 1, 2, and 3, respectively. Immunologically castrated pigs had 
greater SID Lys requirements for phases 1 and 2 compared to PC (0.17 and 0.35 percentage 
points greater for ADG and 0.13 and 0.14 percentage points greater for G:F for phases 1 and 2, 
respectively). After the second injection, when IC pigs are believed to become physiologically 
more similar to PC pigs, the SID Lys requirements continue to be greater for IC (0.55 vs. 0.47% 
for both ADG and G:F). The ADFI of IC increased 4 d after the second injection relative to PC. 
By 2 wk post second injection, the ADFI of IC exceeded that of PC (P < 0.05). Adopting 
immunological castration as a management tool requires an understanding that IC need to be fed 
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differently compared to PC, to maximize growth performance. Immunologically castrated pigs 
have a greater SID Lys requirement throughout the grower and finishing periods compared to the 
PC.  





In the United States, castration of males is a standard procedure in pork production to 
avoid an unpleasant flavor or odor in the meat known as boar taint, even though the growth 
performance advantages of raising entire males (EM) vs. physical castrates (PC) have been well 
characterized (Xue et al., 1997). In 2011, an anti-gonadotropin releasing factor (GnRF) product 
(Improvest, Zoetis Inc., Florham Park, NJ) was approved in the United States to temporarily 
immunologically castrate male pigs. This allows the producer to take advantage of a large 
portion of the benefits of raising EM and addresses the boar taint issue (Dunshea et al., 2001). 
The product temporarily blocks testicular function through production of antibodies to GnRF. A 
recent meta-analysis showed that after the second injection until harvest, the ADG and G:F of 
immunological castrates (IC) exceeded that of EM (Dunshea et al., 2013). While producers 
currently understand the nutrient requirements of PC, there is a need to better define the 
nutritional requirements of IC.  
It has been well documented that feed intake (FI) increases substantially in IC after the 
second immunization (Dunshea et al., 2011, 2013; Huber et al., 2013), but the nature of this 
increase has not been extensively characterized. Therefore, the first objective of this experiment 
was to determine the standardized ileal digestible (SID) Lys requirement of IC and PC through 3 
growth phases. The second objective was to define the FI pattern change in IC immediately after 
the second anti-GnRF injection. The third objective was to determine the digestibility of energy 
in the experimental diets, as a basis for defining the SID Lys requirement as a ratio to dietary 
energy. 
 
MATERIALS AND METHODS 
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 This experiment was conducted at the Iowa State University Swine Nutrition Farm 
(Ames, IA). All experimental procedures adhered to the principles of the ethical and humane use 
of animals for research and were approved by the Iowa State University Institutional Animal 
Care and Use Committee (#12-12-7479-S). 
Animals, housing, and experimental design 
Three hundred male pigs (PIC 359 × C29; Pig Improvement Company, Hendersonville, 
TN), half of which were PC and half of which were EM assigned to be immunologically 
castrated (referred to as IC, even before the second dose of GnRF was administered), were used 
in this experiment. Pigs were selected for inclusion in the experiment based on their ADG during 
a 17 d pre-test period. Pigs with similar pre-test ADG were assigned to 1 of 6 blocks of 25 pigs 
each based on initial BW. Within each block, pigs were randomly assigned to 1 of 5 dietary 
treatments (80, 90, 100, 110, or 120% of estimated SID Lys requirements) and remained on these 
dietary treatments throughout the trial. The experiment was conducted over 3 subsequent growth 
phases (i.e. Lys titration periods) with initial BW of 30.0 ± 0.8 (grower), 64.7 ± 1.4 (early 
finisher), and 111.9 ± 1.9 kg (late finisher) for IC and 32.4 ± 0.6, 69.8 ± 1.0, and 114.5 ± 1.3 kg 
for PC, respectively. Both sexes were similar in age and the experiments were conducted 
simultaneously with both PC and IC for each of the phases. Each treatment within sex consisted 
of 6 pens with 5 pigs per pen. The pens consisted of a partially slatted concrete floor, stainless 
steel dry feeder with 2 covered spaces, and 1 nipple drinker attached to the pen wall. The pens 
provided 1.0 m2 per pig. Pigs were provided ad libitum access to water and feed. Feed intake was 
measured at the same time each day to minimize the impact of the variability of pigs’ eating 
patterns throughout the day on the measurement. Both sexes were housed in the same room to 
avoid confounding of room housed and pig sex. 
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Performance for the Lys titration was determined during a 5 wk period (d 0 to 34) for 
phase 1, a 4 wk period (d 35 to 62) for phase 2, and a 5 wk period (d 77 to 112) for phase 3. Pigs 
were individually weighed and per pen FI was recorded weekly, throughout the experiment, to 
monitor growth performance (ADG, ADFI, and G:F). To minimize variability in pig weights, 
pigs were weighed on 2 consecutive days at the beginning of the experiment, at phase changes, 
and on marketing days, with the average of these 2 weights used in subsequent data analysis. 
Anti-GnRF injections (Improvest, Zoetis Inc., Florham Park, NJ) were administered at 11.5 and 
19 wk of age (average BW = 96.3 ± 1.8 kg for the second injection) for the IC pigs. Timing and 
dosage of the product were in accordance with manufacturer’s directions. The second injection 
was given at the end of the second phase which corresponded with the start of the third dietary 
phase (d 63).  Pigs were fed the phase 3 diets after the second injection until the end of the 
experiment. However, the phase 3 Lys titration commenced 2 wk after the start of the phase 3 
diets (d 77) to avoid confounding due to the rapidly changing FI known to occur immediately 
after the second injection (Dunshea et al., 2011, 2013). On the day of the second injection, pigs 
and feeders were weighed and continued to be weighed every second day for 2 wk (d 63 to 77). 
This facilitated characterizing the changes in ADFI during this transition period. Thereafter on d 
77, the Lys titration was initiated and pigs and feeders were weighed weekly.  
Pigs were marketed at 6 or 7 wk post second injection. The pigs selected at wk 6 post 
injection were the heaviest 90 pigs within each sex. Equal numbers of pigs from each sex were 
marketed at wk 6 post injection. The remaining pigs were marketed the following week. This 




The NRC (2012) modeling program was used to estimate the SID Lys requirement for 
each sex within each period. To maximize model accuracy, inputs for growth rate, initial and 
final BW, days, and FI were obtained from a prior experiment carried out using similar genetics 
housed in the same barn (Elsbernd et al., 2015).  With this information, the SID Lys projected 
requirement and protein deposition (PD) were defined. Treatment SID Lys levels were set at 80, 
90, 100, 110, and 120% of the projected requirement within each sex and within each phase, with 
the 100% treatment set at the projected requirement as defined by the model. 
Diets were formulated to be intentionally simple in design and consisted of corn, soybean 
meal, crystalline amino acids, minerals, and vitamins (Table 1). Diets were formulated to contain 
5% excesses of all essential amino acids other than Lys, to avoid confounding experiment 
outcomes due to a secondary amino acid deficiency. Calcium and standardized total tract 
digestible phosphorus were also formulated to be 5% above requirement, according to the NRC 
(2012) modeling program. In this way, diets were formulated so that Lys was the first limiting 
nutrient. The contributions to SID Lys from soybean meal and from crystalline Lys were held at 
a constant proportion within each dietary phase for each sex. This approach helped to avoid 
confounding the results due to possible differences in Lys digestibility from these 2 sources. 
Diets were formulated to be isocaloric on an NE basis for each phase and based on ingredient NE 
content according to NRC (2012). 
To manufacture the diets, each ingredient was weighed on a scale: corn and soybean meal 
to the nearest 0.5 kg and soybean oil, monocalcium phosphate, and limestone to the nearest 0.05 
kg. All other ingredients were weighed to the nearest gram. All diet sub-samples were analyzed 
at the same time to reduce within assay variability. The SID Lys values in each diet were 
calculated using the actual analyzed total Lys values for corn and soybean meal, determined after 
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diet manufacturing, and multiplying these values by their corresponding SID digestibility values 
as defined by the NRC (2012). The contribution from crystalline Lys, assumed to be 100% 
available, was then added to this total. Titanium dioxide was included in the diet at 0.4% as an 
indigestible marker to allow determination of nutrient and energy digestibility. Diets were 
offered as a dry mash. 
Sample Collection 
Diet sub-samples were collected at random at the time of mixing. At the end of each 
dietary phase, samples were homogenized within diet or ingredient and stored at -20ºC for later 
analysis. Fresh feces were collected from the floor of the pen once a day for 3 consecutive days 
for each dietary phase (d 23 to 25, d 51 to 53, and d 93 to 95 for phases 1, 2, and 3 respectively). 
Samples were collected and stored at -20ºC for later analysis. Fecal samples were thawed, pooled 
within pen and phase, homogenized, subsampled, and oven dried at 65ºC until dry. The dried 
samples were transferred to the Iowa State University Monogastric and Comparative Nutrition 
Laboratory (Ames, IA) for analysis.  
Chemical Analysis 
Before analysis, diet and fecal samples were ground in a Wiley Mill (Variable Speed 
Digital ED-5 Wiley Mill; Thomas Scientific, Swedesboro, NJ) through a 1-mm screen. They 
were analyzed in duplicate for all assays, and repeat analysis occurred for any sample with a CV 
above 1% for DM or GE and above 3% for titanium dioxide. Dry matter was determined by 
drying at 105ºC to a constant weight (Isotemp Oven; Fisher Scientific, Waltham, MA). Gross 
energy was determined by bomb calorimetry (Model 6200; Parr Instrument Co., Moline, IL) 
using benzoic acid as a standard (6,318 kcal GE/kg; Parr Instrument Co., Moline, IL). The 
determined GE of the benzoic acid was 6,324 ± 6 kcal GE/kg. Titanium dioxide was determined 
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using the method of Leone (1973). Feed and ingredient samples were analyzed for total AA 
according to method 994.12 of AOAC. Tryptophan was analyzed according to ISO 
13904:2005E, and CP according to AOAC method 990.03 (Ajinomoto Heartland, Inc.; 
Eddyville, IA). The apparent total tract digestibility (ATTD) of DM and GE were determined 
according to Oresanya et al. (2007). 
Statistical Analysis 
The data for each sex were analyzed separately except for defining the ADFI pattern post 
second injection. The experimental unit was pen and fixed main effect source of variation were 
considered significant if P < 0.05 and trending if P ˃ 0.05 and P < 0.10. Data were evaluated for 
normality using the PROC UNIVARIATE and PROC ROBUSTREG procedures in SAS 9.3 
(SAS Inst. Inc., Cary, NC). An outlier was defined as a value with a standardized robust residual 
of greater than 3 or less than -3. Statistical analysis of growth performance and digestibility 
measures was performed using the PROC MIXED procedure with the fixed effects of treatment 
and block using pen averages. Contrast statements were used to evaluate linear, quadratic, cubic, 
and quartic effects for growth performance and digestibility. 
 To achieve our second experimental objective, the PROC MIXED procedure of SAS was 
used to compare the ADFI of IC and PC post second injection; sex was included in the analysis 
as a fixed effect. When the fixed effect was a significant source of variation, least square means 
were calculated and fixed effect level means separated using the PDIFF option of SAS. 
To determine the Lys requirement, the one-slope broken line regression and the quadratic 
plateau PROC NLIN models were used as described in Robbins et al. (2006). If the one-slope 
broken line regression model produced a Hessian is singular statement, then the quadratic plateau 
model was not tested. The best model was selected based on the Akaike information criterion. 
10 
 
The least square means, already adjusted for pen and block, for each dietary treatment within 
each phase was used, providing 5 data points for each sex within each phase. Calculated SID Lys 
values were used in the analysis.  
 
RESULTS AND DISCUSSION 
General observations 
During phases 1 and 2, overall growth performance was within the normal range for the 
barn. However, phase 3 performance was lower than expected. This phase was conducted in late 
spring during extreme temperature fluctuations in the barn; this may explain the lower than 
expected performance. One pen from the PC treatment was determined to be an outlier according 
to the statistical methods described above and was removed from the analysis. Otherwise, pigs 
remained healthy throughout the duration of the experiment. 
Diet manufacturing and analysis 
 Diet analysis confirmed the amino acids levels were very close to expectation (Tables 2 
to 4). The ingredient assays confirmed all essential AA other than Lys were non-limiting relative 
to Lys. The formulated vs. actual SID Lys percentage values were in agreement and had 
approximately the 0.10 increment between treatments as desired (Table 5). The largest difference 
from formulated to calculated was 0.05% SID Lys with an overall average difference throughout 
each of the 3 phases of 0.02%, indicating accurate diet formulation and manufacturing.  
Growth performance 
Immunological castrates average initial BW was 2.4 kg less than PC, reflecting the 
weight differences of the 2 sexes at the time of delivery to the farm. At market, IC were heavier 
than PC (143.2 ± 1.6 vs. 138.8 ± 1.1 kg; Tables 6 and 7). Lysine did not affect the initial BW for 
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IC (P > 0.05). There was a quadratic Lys effect on initial BW in phases 2, 3, the third Lys 
titration phase, and on market weight (P < 0.05). A quadratic effect was observed for IC ADG 
for phase 1 and overall (P > 0.05). There was a linear Lys effect on ADG for phases 2 and 3 for 
IC (P < 0.05). Lysine had no effect on the phase 3 Lys titration ADG or on ADFI in any of the 
phases for IC (P > 0.05). A quadratic Lys effect on G:F for IC for phases 1, 2, 3, and overall was 
found in the present experiment (P < 0.05). However, lysine had no effect on IC phase 3 Lys 
titration G:F (P > 0.05).  
 Initial BW did not differ among PC treatments (P ˃ 0.05). A quadratic Lys effect on 
initial BW was observed for PC in phases 2, 3, and the phase 3 Lys titration and there was a 
cubic effect on market weight (P < 0.05). There was a quadratic Lys effect in phases 1 and 2 on 
ADG and a cubic Lys effect in phase 3, phase 3 Lys titration, and overall (P < 0.05). There was 
no Lys effect on ADFI for PC in any of the phases (P > 0.05). A linear Lys effect was observed 
for feed efficiency in phases 1 and 2 and a cubic Lys effect was observed in phase 3 and the 
phase 3 Lys titration for PC (P < 0.05). These results suggest that pigs with an inadequate Lys 
supply will have similar FI while growing slower and less efficiently compared to pigs with 
adequate or excess Lys in the diet.  
SID Lys requirements 
 Lysine is 1 of the 9 essential AA for swine and is generally first limiting in swine diets. 
Other AA are expressed as a ratio to Lys according to the ideal protein ratio concept (Fuller et 
al., 1989). Using the model that fit these data the best according to the Akaike information 
criterion, the SID Lys requirement for IC for phases 1, 2, and 3 based on ADG were 1.03, 0.97, 
and 0.55% and based on G:F were 0.99, 0.72, and 0.55% (Table 8). The SID Lys requirement for 
PC for phases 1, 2, and 3 based on ADG were 0.86, 0.62, and 0.47% and based on GF were 0.86, 
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0.58, and 0.47%. It is recognized that some pigs were fed below the determined requirement and 
that may influence the phase 2 and 3 requirements.   
The phase 1 SID Lys requirements for IC and PC aligned well with the NRC 
requirements after adjusting for the greater PD identified for these pigs. For example, the NRC 
(2012) requirement for EM between 50 to 75 kg BW with ADFI of 2.062 kg and a PD of 150 g/d 
is 0.88% SID Lys. Adjusting the NRC (2012) requirement for the greater PD resulted in a very 
similar SID Lys requirement (1.03 vs. 1.03 and 0.99 for ADG and G:F, respectively). The same 
approach also provided close agreement with the NRC (2012) for PC (0.87 vs. 0.86% for both 
G:F and ADG). 
Determined phase 2 and 3 SID Lys requirements were lower than the NRC estimates 
except for IC ADG in phase 2 (0.97 vs. 0.82, respectively). Differences in the Lys requirement 
may be attributed to differences in FI, genetics, and environmental conditions (Schinckel and de 
Lange, 1996). This issue illustrates the importance of expressing the SID Lys requirement of pigs 
in different ways. Nutritionists can then apply these requirements for pigs under their farm 
conditions by adjusting for differences in PD or FI. This generates a requirement that is more 
specific to a given set of conditions rather than use a single estimate based on a single growth 
trial. For example, Table 9 shows other ways of expressing the requirement using the average of 
the ADG and G:F requirements for each phase.  
The Lys requirements for IC were greater than for PC in each phase. This can be 
explained biologically for the first 2 phases during which IC were essentially EM. Entire males 
have greater PD than PC (Dunshea et al., 1993; Elsbernd et al., 2015; NRC, 2012.) due to the 
anabolic effects of androgenic steroids such as testosterone (Dubois et al., 2012). Therefore, the 
Lys requirement would be expected to be greater for IC. 
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After the second injection, the SID Lys requirement was still greater for IC than PC even 
though IC are assumed to become more metabolically similar to PC (Dunshea et al, 2013). The 
difference in the phase 3 SID Lys requirement of IC relative to PC decreased compared to phases 
1 and 2, but was still greater. The results reported herein, although not completely expected, are 
consistent with the results from a previous nitrogen balance experiment from our lab which 
revealed that, 2 wk post second injection, nitrogen retention (g/d) in IC was intermediate to that 
of EM and PC (Elsbernd et al., 2015). Therefore, even though it is widely assumed that the IC 
become metabolically similar to PC after the second anti-GnRF injection, results from this 
experiment and the previously described report indicate they are not metabolically identical. 
There appears to be some carryover effect in IC, reflected in numerically greater nitrogen 
retention (Elsbernd et al., 2015) and a greater Lys requirement. Nonetheless, IC do deviate from 
EM characteristics and performance after the second anti-GnRF injection (Dunshea et al., 2013). 
Although, IC have a greater SID Lys grams per day requirement than PC, after adjusting 
for gain the 2 sex’s requirements are close (differences of 0.5, 0.9, and 0.3 mg SID Lys/g of gain 
for phases 1, 2, and 3, respectively). 
ADFI post second injection 
There are data suggesting that in the period after the second injection until harvest, a 
transition does occur in IC. For example, IC have decreased testosterone levels (Dunshea et al., 
2001; Lealiifano et al., 2011), increased nitrogen excretion and decreased retention (Elsbernd et 
al., 2015; Huber et al., 2013), and decreased androstenone (Lealiifano et al., 2011) and skatole 
concentrations at harvest (Dunshea et al., 2001; Zamaratskaia et al., 2008) in relation to EM. In 
this way, IC become more similar, however, not identical to PC. The transition after the second 
injection also includes a sharp increase in FI. One meta-analysis showed an average increase in 
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daily FI of 429 g/d after the second anti-GnRF injection until harvest (Dunshea et al., 2013). In 
this portion of the current experiment, the objective was to identify the FI pattern of IC in 
relation to PC. It is recognized that IC and PC were fed separate Lys levels and that some pigs 
were fed below their requirement. 
During the week immediately before to the second anti-GnRF injection, as well as up to 4 
d after, the FI of IC remained at 83 to 84% of PC (Table 10). On d 5 to 6 post second injection, 
the FI of IC started to increase (86% of PC). The FI of IC continued to increase so that it was 
similar to that of PC by d 9 to 10 (P > 0.05). However, it exceeded that of PC starting on d 13 to 
14 (P < 0.05). Interestingly, average daily FI of IC relative to that of PC continued to increase 
during wk 3 (P < 0.05) and wk 4 (P < 0.05) after the second anti-GnRF injection. An experiment 
conducted by Dunshea et al. (2011) evaluating FI after the second anti-GnRF injection had 
similar results in that the FI of IC increased 2 wk post second injection such that it was greater 
than EM and became more similar to PC.  
Digestibility 
 Apparent total tract digestibility of GE in IC pigs showed a linear response to Lys for 
each of the 3 dietary phases (P < 0.05; Table 11). The DE of the diet also increased linearly with 
increasing Lys level for each phase (P < 0.05). The diets were formulated to be isocaloric on an 
NE basis. However, as the Lys level increased, so too did the soybean meal and oil content in the 
diet. Because soybean meal has a greater DE content than corn, and oil has a very high DE 
content (NRC, 2012), it is expected that the ATTD of GE and the diet DE content would increase 
as Lys increased. Given the above, it was surprising to observe that there were no differences in 
the ATTD of GE in PC in phases 1 and 2 except for a quadratic diet effect on the ATTD of GE in 
phase 3 (Table 12). In the second and third phase, DE increased linearly as Lys level increased 
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(P < 0.05). The absence of statistically significant differences in ATTD of GE and DM in PC 
was unexpected. The variability in the ATTD of DM and GE measurements were greater in PC 
when compared to IC.  
As the pigs grew, the observed energy digestibility of the diet increased for each of the 
sexes. In general, the predicted DE was greater than the observed DE. However, they became 
closer in relation to each other as the pigs matured (predicted/observed DE = 1.08, 1.05, and 
1.01% for IC and 1.09, 1.06, and 1.01% for PC, for phases 1, 2, and 3, respectively).  It is 
expected that as pigs get older the DE of a given diet would increase due to a more developed 
digestive system.  
 Male pigs which are immunologically castrated must be fed according to their biological 
requirements, which are different than PC, to maximize the use of this technology. The IC pigs 
have greater SID Lys requirements as compared to PC which is an important consideration in 
diet formulation because underestimating the nutrient requirements of IC may result in failure to 
achieve their full potential in terms of growth performance. Another important consideration is to 
note the increase in FI after the second injection for IC. Producers must recognize this and adjust 
their feed budgets accordingly. 
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Table 1. Ingredient composition of phase 1, 2, and 3 diets1 fed to immunologically castrated and 
physically castrated pigs (as-fed basis) 
  Lys percent of NRC (2012) model estimated requirement 
 Phase 1 Phase 2 Phase 3 
Ingredient, % 80%  120%  80%  120%  80%  120%  
Immunological castrates       
   Ground corn 74.36 60.21 80.46 66.32 87.64 73.29 
   Soybean meal, 46.5% CP 20.61 33.25 14.57 27.25 8.43 21.29 
   Soybean oil 0.87 2.23 1.35 2.72 0.85 2.25 
   Monocalcium phosphate 1.27 1.11 1.06 0.90 0.79 0.63 
   Limestone 1.34 1.30 1.18 1.14 0.96 0.94 
   Salt 0.50 0.50 0.50 0.50 0.50 0.50 
   L-Lys HCl 0.19 0.31 0.15 0.27 0.11 0.22 
   L-Thr 0.04 0.11 0.02 0.10 0.00 0.10 
   DL-Met 0.02 0.15 0.00 0.09 0.00 0.05 
   Titanium dioxide 0.40 0.40 0.40 0.40 0.40 0.40 
   Mineral premix2 0.25 0.25 0.15 0.15 0.15 0.15 
   Vitamin premix3 0.17 0.17 0.17 0.17 0.17 0.17 
Physical castrates       
   Ground corn 77.93 63.77 87.18 72.93 91.07 76.70 
   Soybean meal, 46.5% CP 17.93 30.61 9.42 22.21 5.71 18.64 
   Soybean oil 0.37 1.73 0.40 1.80 0.40 1.80 
   Monocalcium phosphate 1.07 0.91 0.72 0.56 0.64 0.47 
   Limestone 1.20 1.16 0.94 0.90 0.87 0.83 
   Salt 0.50 0.50 0.50 0.50 0.50 0.50 
   L-Lys HCl 0.17 0.29 0.12 0.23 0.09 0.20 
   L-Thr 0.02 0.11 0.01 0.11 0.00 0.10 
   DL-Met 0.00 0.13 0.00 0.05 0.00 0.02 
   L-Trp 0.00 0.00 0.00 0.00 0.00 0.01 
   Titanium dioxide 0.40 0.40 0.40 0.40 0.40 0.40 
   Mineral premix2 0.25 0.25 0.15 0.15 0.15 0.15 
   Vitamin premix3 0.17 0.17 0.17 0.17 0.17 0.17 
1 Phase 1 diets fed d 0 to 34 (~ 30 to 65 kg BW). Phase 2 diets fed d 35 to 62 (~ 65 to 100 kg 
BW). Phase 3 diets fed d 63 to 112 (~ 100 to 140 kg BW); second injection of anti-gonadotropin 
releasing factor (Improvest, Zoetis Inc., Florham Park, NJ) occurred on d 63. 
2 Phase 1 diet: Provided per kilogram of diet: Zn, 275 mg from zinc sulfate; Fe, 275 mg from iron 
sulfate; Mn, 65 mg from manganese sulfate; Cu, 28 mg from copper sulfate; I, 0.5 mg from 
calcium iodate; and Se, 0.5 mg from sodium selenite. Phases 2 and 3 diets: Provided per 
kilogram of diet: Zn, 165 mg from zinc sulfate; Fe, 165 mg from iron sulfate; Mn, 39 mg from 
manganese sulfate; Cu, 17 mg from copper sulfate; I, 0.3 mg from calcium iodate; and Se, 0.3 




3 Provided per kilogram of diet: vitamin A, 7,496 IU; vitamin D, 937 IU; vitamin E, 30 IU; 






Table 2. Energy and nutrient composition of phase 11 diets for immunologically castrated and 
physically castrated pigs (as-fed basis) 
  
Lys percent of NRC (2012) model estimated 
requirement 
Item 80%  90%  100%  110%  120%  
Immunological castrates      
   Calculated NE, Mcal/kg2 2.49 2.49 2.49 2.49 2.49 
   Calculated ME, Mcal/kg2 3.29 3.31 3.32 3.34 3.36 
   Calculated DE, Mcal/kg2 3.40 3.43 3.45 3.48 3.50 
   Analyzed values      
      DM, % 88.7 88.6 89.0 89.2 89.3 
      GE, Mcal/kg 3.86 3.88 3.92 3.98 3.98 
      DE, Mcal/kg 3.13 3.13 3.17 3.30 3.31 
      CP, % 17.2 17.3 19.4 20.3 21.5 
      Indispensable AA, total %      
         Lys 0.98 1.10 1.20 1.30 1.40 
         Met 0.27 0.32 0.35 0.40 0.46 
         Met + Cys 0.54 0.60 0.66 0.71 0.78 
         Thr 0.66 0.70 0.79 0.83 0.90 
         Trp 0.18 0.19 0.23 0.23 0.25 
         Val 0.77 0.82 0.89 0.90 0.96 
         Ile 0.69 0.74 0.81 0.82 0.88 
Physical castrates      
   Calculated NE, Mcal/kg2 2.49 2.49 2.49 2.49 2.49 
   Calculated ME, Mcal/kg2 3.28 3.29 3.31 3.33 3.34 
   Calculated DE, Mcal/kg2 3.38 3.41 3.43 3.46 3.49 
   Analyzed values      
      DM, % 88.9 88.9 89.2 89.5 90.0 
      GE, Mcal/kg 3.83 3.85 3.89 3.93 3.96 
      DE, Mcal/kg 3.15 3.11 3.15 3.19 3.16 
      CP, % 16.2 16.7 17.4 19.8 19.3 
      Indispensable AA, total %      
         Lys 0.95 1.02 1.10 1.19 1.25 
         Met 0.25 0.28 0.33 0.37 0.41 
         Met + Cys 0.51 0.55 0.61 0.67 0.71 
         Thr 0.62 0.67 0.72 0.79 0.83 
         Trp 0.16 0.18 0.20 0.22 0.22 
         Val 0.74 0.77 0.82 0.87 0.89 
         Ile 0.65 0.69 0.74 0.79 0.80 
1Phase 1 diets fed d 0 to 34 (~30 to 65 kg BW). 
2 NRC, 2012. 
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Table 3. Energy and nutrient composition of phase 21 diets for immunologically castrated and 
physically castrated pigs (as-fed basis) 
  
Lys percent of NRC (2012) model estimated 
requirement 
Item 80%  90%  100%  110%  120%  
Immunological castrates      
   Calculated NE, Mcal/kg2 2.56 2.56 2.56 2.56 2.56 
   Calculated ME, Mcal/kg2 3.34 3.35 3.37 3.39 3.40 
   Calculated DE, Mcal/kg2 3.43 3.46 3.48 3.51 3.53 
   Analyzed values      
      DM, % 89.3 89.5 89.5 89.5 89.8 
      GE, Mcal/kg 3.86 3.90 3.91 3.95 3.98 
      DE, Mcal/kg 3.19 3.31 3.27 3.36 3.38 
      CP, % 13.4 14.4 15.9 17.3 19.4 
      Indispensable AA, total %      
         Lys 0.78 0.83 0.95 1.03 1.16 
         Met 0.22 0.25 0.30 0.31 0.35 
         Met + Cys 0.47 0.50 0.56 0.58 0.65 
         Thr 0.53 0.57 0.65 0.70 0.80 
         Trp 0.14 0.16 0.18 0.20 0.22 
         Val 0.61 0.68 0.72 0.68 0.79 
         Ile 0.48 0.60 0.64 0.76 0.87 
Physical castrates      
   Calculated NE, Mcal/kg2 2.56 2.56 2.56 2.56 2.56 
   Calculated ME, Mcal/kg2 3.31 3.33 3.35 3.36 3.38 
   Calculated DE, Mcal/kg2 3.39 3.42 3.44 3.47 3.50 
   Analyzed values      
      DM, % 88.9 89.1 88.6 88.9 89.2 
      GE, Mcal/kg 3.81 3.83 3.87 3.92 3.95 
      DE, Mcal/kg 3.21 3.19 3.23 3.30 3.34 
      CP, % 11.4 13.8 14.1 15.3 17.4 
      Indispensable AA, total %      
         Lys 0.59 0.69 0.80 0.89 1.01 
         Met 0.20 0.23 0.25 0.27 0.30 
         Met + Cys 0.41 0.46 0.50 0.53 0.58 
         Thr 0.43 0.51 0.58 0.65 0.72 
         Trp 0.11 0.14 0.14 0.15 0.19 
         Val 0.51 0.58 0.62 0.64 0.81 
         Ile 0.39 0.46 0.51 0.53 0.72 
1 Phase 2 diets fed d 35 to 62 (~ 65 to 100 kg BW). 
2 NRC, 2012. 
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Table 4. Energy and nutrient composition of phase 31 diets for immunologically castrated and 
physically castrated pigs (as-fed basis) 
  
Lys percent of NRC (2012) model estimated 
requirement 
Item 80%  90%  100%  110%  120%  
Immunological castrates      
   Calculated NE, Mcal/kg2 2.59 2.59 2.59 2.59 2.59 
   Calculated ME, Mcal/kg2 3.33 3.35 3.37 3.38 3.40 
   Calculated DE, Mcal/kg2 3.41 3.44 3.46 3.49 3.52 
   Analyzed values      
      DM, % 88.9 88.9 89.0 89.5 89.7 
      GE, Mcal/kg 3.83 3.90 3.89 3.96 3.98 
      DE, Mcal/kg 3.32 3.40 3.37 3.48 3.51 
      CP, % 11.2 12.6 13.2 14.7 16.0 
      Indispensable AA, total %      
         Lys 0.57 0.62 0.77 0.83 0.96 
         Met 0.20 0.21 0.25 0.26 0.29 
         Met + Cys 0.42 0.43 0.49 0.50 0.55 
         Thr 0.42 0.46 0.54 0.59 0.68 
         Trp 0.11 0.11 0.15 0.16 0.18 
         Val 0.52 0.53 0.62 0.69 0.75 
         Ile 0.41 0.42 0.50 0.60 0.66 
Physical castrates      
   Calculated NE, Mcal/kg2 2.59 2.59 2.59 2.59 2.59 
   Calculated ME, Mcal/kg2 3.32 3.34 3.35 3.37 3.39 
   Calculated DE, Mcal/kg2 3.39 3.42 3.44 3.47 3.50 
   Analyzed values      
      DM, % 89.3 88.8 89.3 89.5 88.5 
      GE, Mcal/kg 3.83 3.84 3.87 3.91 3.95 
      DE, Mcal/kg 3.35 3.36 3.44 3.41 3.42 
      CP, % 10.0 11.5 12.4 13.7 15.3 
      Indispensable AA, total %      
         Lys 0.47 0.57 0.67 0.73 0.89 
         Met 0.19 0.20 0.22 0.23 0.26 
         Met + Cys 0.39 0.43 0.44 0.46 0.52 
         Thr 0.38 0.44 0.50 0.55 0.68 
         Trp 0.10 0.11 0.13 0.15 0.17 
         Val 0.47 0.53 0.56 0.63 0.68 
         Ile 0.35 0.40 0.44 0.54 0.59 
1 Phase 3 diets fed d 63 to 112 (~ 100 to 140 kg BW); second anti-gonadotropin releasing factor 
injection (Improvest, Zoetis Inc., Florham Park, NJ) occurred on d 63. 
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Table 5. Formulated, analyzed, and “actual” dietary Lys content by phase for immunologically castrated and physically castrated male 
pigs 
   Sex 
 Immunological castrates Physical castrates 
 Lys percent of NRC (2012) model estimated requirement 
Item, % 80% 90% 100% 110% 120% 80% 90% 100% 110% 120% 
Phase 1 (~ 30 to 65 kg BW)           
   Formulated total1 0.95 1.06 1.17 1.27 1.38 0.86 0.97 1.08 1.18 1.29 
   Analyzed total2 0.98 1.10 1.20 1.30 1.40 0.95 1.02 1.10 1.19 1.25 
   Formulated SID1 0.83 0.93 1.03 1.13 1.23 0.75 0.85 0.95 1.05 1.15 
   “Actual” SID3  0.84 0.93 1.03 1.12 1.22 0.76 0.86 0.95 1.05 1.14 
Phase 2 (~ 65 to 100 kg BW)           
   Formulated total 0.75 0.86 0.97 1.07 1.18 0.60 0.71 0.82 0.92 1.03 
   Analyzed total 0.78 0.83 0.95 1.03 1.16 0.59 0.69 0.80 0.89 1.01 
   Formulated SID 0.65 0.75 0.85 0.95 1.05 0.50 0.60 0.70 0.80 0.90 
   “Actual” SID 0.63 0.72 0.82 0.91 1.00 0.49 0.58 0.68 0.77 0.86 
Phase 34 (~ 100 to 140 kg BW)           
   Formulated total 0.55 0.66 0.77 0.88 0.99 0.47 0.58 0.69 0.79 0.90 
   Analyzed total 0.57 0.62 0.77 0.83 0.96 0.47 0.57 0.67 0.73 0.89 
   Formulated SID 0.47 0.57 0.67 0.77 0.87 0.39 0.49 0.59 0.69 0.79 
   “Actual” SID 0.46 0.55 0.65 0.74 0.84 0.38 0.47 0.57 0.67 0.76 
1 NRC (2012).  
2 AOAC 994.12 (Ajinomoto Heartland, Inc.; Eddyville, IA). 
3 “Actual” SID = SID contribution of corn + SBM + L-Lys HCl. 
SID contribution of ingredient = analyzed total Lys × % contribution of the diet (Table 1) × SID Lys digestibility (NRC, 2012). 






Table 6. Effects of standardized ileal digestible Lys level on growth performance and feed efficiency of immunologically castrated 
pigs by dietary phase1 
  Lys percent of NRC (2012) model estimated requirement  P-value 
 Item 80% 90% 100% 110% 120% SEM linear quadratic cubic 
No. of pens 6 6 6 6 6 - - - - 
Initial BW, kg2          
     phase 1 29.9 30.0 30.0 30.1 30.0 0.08 0.702 0.491 0.738 
     phase 2 63.0 64.1 65.9 65.9 64.8 0.72 0.029 0.036 0.437 
     phase 3 93.2 96.0 98.9 99.7 98.1 1.22 0.002 0.024 0.577 
     phase 3 Lys titration 105.9 110.0 115.3 114.9 113.6 1.44 <0.001 0.006 0.683 
     market 136.6 141.9 146.6 146.3 144.9 1.83 0.002 0.013 0.994 
ADG, kg/d          
     phase 1 0.95 0.97 1.03 1.03 0.98 0.018 0.061 0.004 0.205 
     phase 2 1.08 1.14 1.16 1.20 1.19 0.022 0.001 0.129 0.975 
     phase 3 0.96 1.03 1.04 1.08 1.05 0.027 0.012 0.117 0.844 
     phase 3 Lys titration 0.96 1.03 1.01 1.07 1.01 0.034 0.247 0.200 0.746 
     overall  0.99 1.04 1.07 1.10 1.06 0.018 0.002 0.009 0.528 
ADFI, kg/d          
     phase 1 2.04 1.97 2.02 2.00 1.91 0.040 0.070 0.483 0.133 
     phase 2 2.90 2.77 2.80 2.84 2.80 0.062 0.495 0.417 0.255 
     phase 3 3.49 3.40 3.59 3.59 3.56 0.076 0.209 0.785 0.222 
     phase 3 Lys titration 3.63 3.56 3.75 3.77 3.72 0.086 0.165 0.607 0.254 
     overall 2.87 2.77 2.85 2.84 2.79 0.050 0.617 0.994 0.191 
G:F          
     phase 1 0.45 0.48 0.50 0.50 0.50 0.006 <0.001 0.002 0.376 
     phase 2 0.37 0.41 0.42 0.42 0.43 0.006 <0.001 0.023 0.119 
     phase 3 0.28 0.30 0.29 0.31 0.30 0.005 0.002 0.014 0.201 
     phase 3 Lys titration 0.27 0.29 0.27 0.28 0.27 0.006 0.572 0.149 0.393 
     overall 0.34 0.37 0.37 0.38 0.38 0.004 <0.001 0.001 0.177 
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1 Anti-gonadotropin releasing factor injections (Improvest, Zoetis Inc., Florham Park, NJ) given at 11.5 and 19 wk of age. Phase 1 
diets were fed d 0 to 34, phase 2 diets were fed from d 35 to 62, and phase 3 diets were fed from d 63 to 112. The second injection was 
given at the start of phase 3 (d 63). The phase 3 Lys titration commenced 2 wk post second injection (d 77 to 112). 




Table 7. Effects of standardized ileal digestible Lys level on growth performance and feed efficiency of physically castrated pigs by 
dietary phase1 
  Lys percent of NRC (2012) model estimated requirement  P-value 
 Item 80% 90% 100% 110% 120% SEM linear quadratic cubic 
No. of pens 5 6 6 6 6 - - - - 
Initial BW, kg2          
     phase 1 32.1 32.1 32.2 32.2 32.2 0.08 0.509 0.991 0.912 
     phase 2 67.4 69.3 70.2 70.2 70.0 0.50 0.002 0.017 0.654 
     phase 3 95.6 100.6 102.5 102.2 102.7 0.88 <0.001 0.003 0.144 
     phase 3 Lys titration 107.0 113.8 115.5 116.1 117.3 1.12 <0.001 0.010 0.091 
     market3 130.1 139.5 140.3 139.9 141.6 1.09 <0.001 0.001 0.004 
ADG, kg/d          
     phase 1 1.01 1.07 1.08 1.08 1.08 0.016 0.005 0.024 0.529 
     phase 2 1.01 1.11 1.16 1.14 1.17 0.022 <0.001 0.019 0.132 
     phase 33 0.73 0.88 0.86 0.86 0.89 0.019 <0.001 0.015 0.003 
     phase 3 Lys titration3 0.69 0.83 0.81 0.78 0.81 0.023 0.022 0.013 0.006 
     overall3 0.89 1.00 1.01 1.01 1.03 0.013 <0.001 0.001 0.011 
ADFI, kg/d          
     phase 1 2.39 2.36 2.49 2.37 2.33 0.036 0.278 0.057 0.440 
     phase 2 3.27 3.35 3.46 3.35 3.38 0.050 0.227 0.105 0.540 
     phase 3 3.12 3.31 3.24 3.21 3.28 0.054 0.236 0.298 0.052 
     phase 3 Lys titration 3.05 3.26 3.16 3.14 3.17 0.058 0.529 0.233 0.057 
     overall 2.93 3.00 3.05 2.97 2.99 0.036 0.441 0.097 0.326 
G:F          
     phase 1 0.41 0.44 0.43 0.45 0.46 0.005 <0.001 0.953 0.125 
     phase 2 0.31 0.34 0.34 0.35 0.35 0.004 <0.001 0.052 0.127 
     phase 33 0.23 0.27 0.27 0.27 0.28 0.004 <0.001 0.012 0.007 
     phase 3 Lys titration3 0.23 0.26 0.26 0.25 0.26 0.006 0.008 0.025 0.030 
     overall4 0.30 0.33 0.33 0.34 0.34 0.003 <0.001 0.004 0.015 
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1 Phase 1 diets were fed d 0 to 34, phase 2 diets were fed from d 35 to 62, and phase 3 diets were fed from d 63 to 112. The phase 3 
Lys titration commenced 2 wk after the start of the third dietary phase (d 77 to 112).  
2 The average BW of 2 consecutive weigh dates. 
3 Quartic effect not significant (P > 0.05). 
4 Quartic effect significant (P = 0.040).
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Table 8. Standardized ileal digestible Lys requirement (%) as determined by one-slope broken line regression and quadratic plateau 
regression models for immunologically castrated and physically castrated pigs 
1 IC = immunological castrate; PC = physical castrate. 
2 If the one-slope broken line regression produced a Hessian is singular statement, then the quadratic plateau model was not tested. 
3 For the Lys titration, performance was measured 2 wk post the start of the phase 3 (d 63) diet change which corresponded to 2 wk 











  IC PC 










Phase 1 (~ 30 to 65 kg BW)         
   ADG 1.03 -33.7 1.08 -33.0 0.862    
   G:F 0.99 -376.4 1.07 -64.5 0.862    
Phase 2 (~ 65 to 100 kg BW)         
   ADG 0.89 -41.5 0.97 -42.6 0.62 -40.4 0.69 -40.3 
   G:F 0.722    0.582    
Phase 33 (~ 115 to 140 kg BW)         
   ADG 0.552    0.472    
   G:F 0.552    0.472    
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Table 9. Standardized ileal digestible (SID) Lys requirements for immunologically castrated and 
physically castrated pigs based on averaging the ADG and G:F requirements of the one slope 
broken line regression model 
  Sex1 
  IC PC 
Item   
Phase 1 (~ 30 to 65 kg BW)   
   g SID Lys/d 20.2 20.7 
   mg SID Lys/g PD2 115.4 133.5 
   g SID Lys/Mcal ME 3.04 2.60 
   g SID Lys/Mcal NE 4.05 3.45 
   mg SID Lys/g gain 20.2 19.7 
Phase 2 (~65 to 100 kg BW)   
   g SID Lys/d 22.7 20.2 
   mg SID Lys/g PD 129.6 144.3 
   g SID Lys/Mcal ME 2.40 1.79 
   g SID Lys/Mcal NE 3.16 2.34 
   mg SID Lys/g gain 19.4 18.5 
Phase 33 (~ 115 to 140 kg BW)   
   g SID Lys/d 19.8 14.9 
   mg SID Lys/g PD 123.8 99.3 
   g SID Lys/Mcal ME 1.63 1.40 
   g SID Lys/Mcal NE 2.13 1.82 
   mg SID Lys/g gain 19.9 19.6 
1 IC = immunological castrate; PC = physical castrate. 
2 PD = protein deposited. The estimates of PD were obtained by entering in values for feed 
intake, initial and final BW, and days into the NRC modeling program. The PD value was 
adjusted so that the model’s predicted values closely matched the observed ones from a previous 
experiment (Elsbernd et al., 2015). 
3 For the Lys titration, performance was measured 2 wk post the start of the phase 3 (d 63); diet 
change which corresponded to 2 wk post second anti-gonadotrophin releasing factor injection 













Table 10. Effects of sex on ADFI 1 wk before and 4 wk post second anti-gonadotropin releasing 
factor injection 
 Sex1    
Item IC ADFI PC ADFI SEM P-value % IC of PC 
No. of pens 30 29 - - - 
Day in relation to second injection      
-7 (wk before)2 2.91b 3.52a 0.045 <0.001 83 
1-2 2.83b 3.36a 0.044 <0.001 84 
3-4 2.89b 3.50a 0.049 <0.001 83 
5-6 2.97b 3.46a 0.077 <0.001 86 
7-8 3.01b 3.21a 0.050 0.009 94 
9-10 3.36 3.46 0.059 0.193 97 
11-12 3.66 3.52 0.075 0.193 104 
13-14 3.55a 3.31b 0.061 0.007 107 
15-21 3.74a 3.39b 0.047 <0.001 110 
22-28 3.86a 3.37b 0.047 <0.001 115 
ab Within a row, means without a common superscript differ (P < 0.05). 
1 IC = immunological castrate; PC = physical castrate. 








Table 11. Effects of standardized ileal digestible Lys level on apparent total tract digestibility (ATTD)1 of GE and gross and digestible 
energy of diets fed to immunologically castrated pigs by dietary phase (DM basis) 
  Lys percent of NRC (2012) model estimated requirement  P-value 
Item 80% 90% 100% 110% 120% SEM linear quadratic cubic 
No. of pens 6 6 6 6 6 - - - - 
Phase 12          
ATTD, %          
   GE 81.0 80.7 80.8 83.0 83.0 0.55 0.002 0.231 0.127 
Energy, Mcal/kg DM          
   GE 4.35 4.37 4.41 4.46 4.46 - - -  
   DE 3.53 3.53 3.56 3.70 3.71 0.024 < 0.001 0.275 0.055 
Phase 23          
ATTD, %          
   GE 82.8 84.9 83.6 85.1 85.0 0.44 0.005 0.336 0.188 
Energy, Mcal/kg DM          
   GE 4.32 4.35 4.37 4.41 4.43 - - -  
   DE 3.58 3.70 3.66 3.75 3.77 0.019 < 0.001 0.393 0.163 
Phase 34          
ATTD, %          
   GE 86.8 87.2 86.7 87.8 88.2 0.33 0.003 0.181 0.948 
Energy, Mcal/kg DM          
   GE 4.30 4.38 4.37 4.43 4.44 - - -  
   DE 3.74 3.82 3.79 3.89 3.92 0.015 < 0.001 0.798 0.291 
1 ATTD (% ) = 100 – [(100 × diet concentration of TiO2 × fecal concentration of component) / (fecal concentration of TiO2 × feed 
concentration of component)] (Oresanya et al., 2007). 
2 Feces collected on d 23 to 25 during phase 1. 
3 Feces collected on d 51 to 53 during phase 2. 
4 Feces collected on d 93 to 95 during phase 3; collection started 30 d post second anti-gonadotropin releasing factor injection 
(Improvest, Zoetis Inc., Florham Park, NJ). 
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Table 12. Effects of standardized ileal digestible Lys level on apparent total tract digestibility (ATTD)1 of GE and gross and digestible 
energy of diets fed to physically castrated pigs by dietary phase (DM basis) 
 
1 ATTD (%) = 100 – [(100 × diet concentration of TiO2 × fecal concentration of component) / (fecal concentration of TiO2 × feed 
concentration of component)] (Oresanya et al., 2007). 
2 Feces collected on d 23 to 25 during phase 1. 
3 Feces collected on d 52 to 53 during phase 2. 
4 Feces collected on d 93 to 95 during phase 3. 
  Lys percent of NRC (2012) model estimated requirement  P-value 
Item 80% 90%  100%  110%  120% SEM linear quadratic cubic 
No. of pens 5 6 6 6 6 - - -  
Phase 12          
ATTD, %          
   GE 82.1 80.7 80.9 82.1 80.5 0.69 0.383 0.745 0.058 
Energy, Mcal/kg DM          
   GE 4.30 4.33 4.36 4.39 4.40 - -   
   DE 3.54 3.50 3.53 3.58 3.53 0.030 0.460 0.913 0.073 
Phase 23          
ATTD, %          
   GE 84.3 83.4 83.3 84.4 84.8 0.65 0.383 0.137 0.519 
Energy, Mcal/kg DM          
   GE 4.29 4.30 4.38 4.40 4.42 - -   
   DE 3.61 3.58 3.64 3.71 3.75 0.028 <0.001 0.218 0.191 
Phase 34          
ATTD, %          
   GE5 87.4 87.7 89.0 87.4 86.6 0.48 0.262 0.012 0.866 
Energy, Mcal/kg DM          
   GE 4.29 4.32 4.33 4.36 4.46 - -   
   DE 3.75 3.79 3.85 3.82 3.87 0.021 0.002 0.350 0.328 
